Braxia Scientific Corp.
Braxia Scientific Corp. (BRAXF) Stock Competitors & Peer Comparison
See (BRAXF) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| BRAXF | $0.00 | +0.00% | 1.3B | -0.03 | -$0.04 | N/A |
| NONOF | $57.17 | +0.12% | 251.2B | 14.53 | $3.89 | +3.06% |
| CSLLY | $69.30 | -1.59% | 134.2B | 22.50 | $3.08 | +1.91% |
| CMXHF | $145.59 | -1.73% | 70.6B | 23.68 | $6.16 | +1.90% |
| UCBJF | $235.70 | +0.74% | 44.8B | 29.50 | $7.99 | +1.34% |
| UCBJY | $116.70 | +0.66% | 44.4B | 29.23 | $4.00 | +0.76% |
| ARGNF | $683.14 | +10.28% | 41.8B | 34.78 | $19.64 | N/A |
| ODTC | $22,005.00 | +29.44% | 24.1B | 1.07 | $20,580.00 | N/A |
| IVBXF | $12.90 | +1.34% | 22.1B | -1290.00 | -$0.01 | N/A |
| SBMFF | $0.99 | +0.00% | 17.7B | 32.97 | $0.03 | +0.90% |
Stock Comparison
BRAXF vs NONOF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, NONOF has a market cap of 251.2B. Regarding current trading prices, BRAXF is priced at $0.00, while NONOF trades at $57.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas NONOF's P/E ratio is 14.53. In terms of profitability, BRAXF's ROE is -2.49%, compared to NONOF's ROE of +0.78%. Regarding short-term risk, BRAXF is more volatile compared to NONOF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check NONOF's competition here
BRAXF vs CSLLY Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, CSLLY has a market cap of 134.2B. Regarding current trading prices, BRAXF is priced at $0.00, while CSLLY trades at $69.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas CSLLY's P/E ratio is 22.50. In terms of profitability, BRAXF's ROE is -2.49%, compared to CSLLY's ROE of +0.26%. Regarding short-term risk, BRAXF is more volatile compared to CSLLY. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check CSLLY's competition here
BRAXF vs CMXHF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, CMXHF has a market cap of 70.6B. Regarding current trading prices, BRAXF is priced at $0.00, while CMXHF trades at $145.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas CMXHF's P/E ratio is 23.68. In terms of profitability, BRAXF's ROE is -2.49%, compared to CMXHF's ROE of +0.15%. Regarding short-term risk, BRAXF is more volatile compared to CMXHF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check CMXHF's competition here
BRAXF vs UCBJF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, UCBJF has a market cap of 44.8B. Regarding current trading prices, BRAXF is priced at $0.00, while UCBJF trades at $235.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas UCBJF's P/E ratio is 29.50. In terms of profitability, BRAXF's ROE is -2.49%, compared to UCBJF's ROE of +0.11%. Regarding short-term risk, BRAXF is more volatile compared to UCBJF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check UCBJF's competition here
BRAXF vs UCBJY Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, UCBJY has a market cap of 44.4B. Regarding current trading prices, BRAXF is priced at $0.00, while UCBJY trades at $116.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas UCBJY's P/E ratio is 29.23. In terms of profitability, BRAXF's ROE is -2.49%, compared to UCBJY's ROE of +0.11%. Regarding short-term risk, BRAXF is more volatile compared to UCBJY. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check UCBJY's competition here
BRAXF vs ARGNF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, ARGNF has a market cap of 41.8B. Regarding current trading prices, BRAXF is priced at $0.00, while ARGNF trades at $683.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas ARGNF's P/E ratio is 34.78. In terms of profitability, BRAXF's ROE is -2.49%, compared to ARGNF's ROE of +0.19%. Regarding short-term risk, BRAXF is more volatile compared to ARGNF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check ARGNF's competition here
BRAXF vs ODTC Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, ODTC has a market cap of 24.1B. Regarding current trading prices, BRAXF is priced at $0.00, while ODTC trades at $22,005.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas ODTC's P/E ratio is 1.07. In terms of profitability, BRAXF's ROE is -2.49%, compared to ODTC's ROE of +0.07%. Regarding short-term risk, BRAXF is more volatile compared to ODTC. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check ODTC's competition here
BRAXF vs IVBXF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, IVBXF has a market cap of 22.1B. Regarding current trading prices, BRAXF is priced at $0.00, while IVBXF trades at $12.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas IVBXF's P/E ratio is -1290.00. In terms of profitability, BRAXF's ROE is -2.49%, compared to IVBXF's ROE of -0.01%. Regarding short-term risk, BRAXF is more volatile compared to IVBXF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check IVBXF's competition here
BRAXF vs SBMFF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, SBMFF has a market cap of 17.7B. Regarding current trading prices, BRAXF is priced at $0.00, while SBMFF trades at $0.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas SBMFF's P/E ratio is 32.97. In terms of profitability, BRAXF's ROE is -2.49%, compared to SBMFF's ROE of +0.11%. Regarding short-term risk, BRAXF is more volatile compared to SBMFF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check SBMFF's competition here
BRAXF vs SBHMY Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, SBHMY has a market cap of 17.4B. Regarding current trading prices, BRAXF is priced at $0.00, while SBHMY trades at $19.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas SBHMY's P/E ratio is 32.50. In terms of profitability, BRAXF's ROE is -2.49%, compared to SBHMY's ROE of +0.11%. Regarding short-term risk, BRAXF is more volatile compared to SBHMY. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check SBHMY's competition here
BRAXF vs WXXWY Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, WXXWY has a market cap of 17.2B. Regarding current trading prices, BRAXF is priced at $0.00, while WXXWY trades at $8.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas WXXWY's P/E ratio is 31.24. In terms of profitability, BRAXF's ROE is -2.49%, compared to WXXWY's ROE of +0.08%. Regarding short-term risk, BRAXF is more volatile compared to WXXWY. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check WXXWY's competition here
BRAXF vs WXIBF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, WXIBF has a market cap of 17.1B. Regarding current trading prices, BRAXF is priced at $0.00, while WXIBF trades at $4.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas WXIBF's P/E ratio is 30.00. In terms of profitability, BRAXF's ROE is -2.49%, compared to WXIBF's ROE of +0.08%. Regarding short-term risk, BRAXF is more volatile compared to WXIBF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check WXIBF's competition here
BRAXF vs GNMSF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, GNMSF has a market cap of 15.1B. Regarding current trading prices, BRAXF is priced at $0.00, while GNMSF trades at $245.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas GNMSF's P/E ratio is 12.67. In terms of profitability, BRAXF's ROE is -2.49%, compared to GNMSF's ROE of +0.28%. Regarding short-term risk, BRAXF is more volatile compared to GNMSF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check GNMSF's competition here
BRAXF vs TRSBF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, TRSBF has a market cap of 9.3B. Regarding current trading prices, BRAXF is priced at $0.00, while TRSBF trades at $3.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas TRSBF's P/E ratio is 32.50. In terms of profitability, BRAXF's ROE is -2.49%, compared to TRSBF's ROE of +0.14%. Regarding short-term risk, BRAXF is more volatile compared to TRSBF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check TRSBF's competition here
BRAXF vs AKBLF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, AKBLF has a market cap of 6.8B. Regarding current trading prices, BRAXF is priced at $0.00, while AKBLF trades at $28.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas AKBLF's P/E ratio is 41.36. In terms of profitability, BRAXF's ROE is -2.49%, compared to AKBLF's ROE of +0.18%. Regarding short-term risk, BRAXF is more volatile compared to AKBLF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check AKBLF's competition here
BRAXF vs AAVXF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, AAVXF has a market cap of 5.8B. Regarding current trading prices, BRAXF is priced at $0.00, while AAVXF trades at $76.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas AAVXF's P/E ratio is -22.33. In terms of profitability, BRAXF's ROE is -2.49%, compared to AAVXF's ROE of -2.11%. Regarding short-term risk, BRAXF is more volatile compared to AAVXF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check AAVXF's competition here
BRAXF vs ABCZF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, ABCZF has a market cap of 5.7B. Regarding current trading prices, BRAXF is priced at $0.00, while ABCZF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas ABCZF's P/E ratio is 2225.00. In terms of profitability, BRAXF's ROE is -2.49%, compared to ABCZF's ROE of -0.01%. Regarding short-term risk, BRAXF is more volatile compared to ABCZF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check ABCZF's competition here
BRAXF vs SHJBF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, SHJBF has a market cap of 5.4B. Regarding current trading prices, BRAXF is priced at $0.00, while SHJBF trades at $1.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas SHJBF's P/E ratio is -10.94. In terms of profitability, BRAXF's ROE is -2.49%, compared to SHJBF's ROE of -0.14%. Regarding short-term risk, BRAXF is more volatile compared to SHJBF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check SHJBF's competition here
BRAXF vs INCPF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, INCPF has a market cap of 4.9B. Regarding current trading prices, BRAXF is priced at $0.00, while INCPF trades at $3.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas INCPF's P/E ratio is -108.67. In terms of profitability, BRAXF's ROE is -2.49%, compared to INCPF's ROE of -0.04%. Regarding short-term risk, BRAXF is more volatile compared to INCPF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check INCPF's competition here
BRAXF vs GNNSF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, GNNSF has a market cap of 4.7B. Regarding current trading prices, BRAXF is priced at $0.00, while GNNSF trades at $2.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas GNNSF's P/E ratio is -27.50. In terms of profitability, BRAXF's ROE is -2.49%, compared to GNNSF's ROE of +1.07%. Regarding short-term risk, BRAXF is more volatile compared to GNNSF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check GNNSF's competition here
BRAXF vs ZLDPF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, ZLDPF has a market cap of 4.7B. Regarding current trading prices, BRAXF is priced at $0.00, while ZLDPF trades at $66.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas ZLDPF's P/E ratio is 4.55. In terms of profitability, BRAXF's ROE is -2.49%, compared to ZLDPF's ROE of +0.65%. Regarding short-term risk, BRAXF is more volatile compared to ZLDPF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check ZLDPF's competition here
BRAXF vs LABFF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, LABFF has a market cap of 4.6B. Regarding current trading prices, BRAXF is priced at $0.00, while LABFF trades at $90.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas LABFF's P/E ratio is 28.95. In terms of profitability, BRAXF's ROE is -2.49%, compared to LABFF's ROE of +0.35%. Regarding short-term risk, BRAXF is more volatile compared to LABFF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check LABFF's competition here
BRAXF vs CAMRF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, CAMRF has a market cap of 4.1B. Regarding current trading prices, BRAXF is priced at $0.00, while CAMRF trades at $68.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas CAMRF's P/E ratio is 55.08. In terms of profitability, BRAXF's ROE is -2.49%, compared to CAMRF's ROE of +0.21%. Regarding short-term risk, BRAXF is more volatile compared to CAMRF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check CAMRF's competition here
BRAXF vs ASPHF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, ASPHF has a market cap of 3.9B. Regarding current trading prices, BRAXF is priced at $0.00, while ASPHF trades at $10.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas ASPHF's P/E ratio is -20.88. In terms of profitability, BRAXF's ROE is -2.49%, compared to ASPHF's ROE of -2.50%. Regarding short-term risk, BRAXF is more volatile compared to ASPHF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check ASPHF's competition here
BRAXF vs TLPPF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, TLPPF has a market cap of 3.7B. Regarding current trading prices, BRAXF is priced at $0.00, while TLPPF trades at $11.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas TLPPF's P/E ratio is 550.50. In terms of profitability, BRAXF's ROE is -2.49%, compared to TLPPF's ROE of +0.06%. Regarding short-term risk, BRAXF is more volatile compared to TLPPF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check TLPPF's competition here
BRAXF vs BVNKF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, BVNKF has a market cap of 2.9B. Regarding current trading prices, BRAXF is priced at $0.00, while BVNKF trades at $37.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas BVNKF's P/E ratio is 14.20. In terms of profitability, BRAXF's ROE is -2.49%, compared to BVNKF's ROE of +0.12%. Regarding short-term risk, BRAXF is more volatile compared to BVNKF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check BVNKF's competition here
BRAXF vs BVNRY Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, BVNRY has a market cap of 2.9B. Regarding current trading prices, BRAXF is priced at $0.00, while BVNRY trades at $12.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas BVNRY's P/E ratio is 14.11. In terms of profitability, BRAXF's ROE is -2.49%, compared to BVNRY's ROE of +0.12%. Regarding short-term risk, BRAXF is more volatile compared to BVNRY. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check BVNRY's competition here
BRAXF vs REGMF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, REGMF has a market cap of 2.8B. Regarding current trading prices, BRAXF is priced at $0.00, while REGMF trades at $5.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas REGMF's P/E ratio is -13.32. In terms of profitability, BRAXF's ROE is -2.49%, compared to REGMF's ROE of -0.63%. Regarding short-term risk, BRAXF is more volatile compared to REGMF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check REGMF's competition here
BRAXF vs TKBIF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, TKBIF has a market cap of 2.8B. Regarding current trading prices, BRAXF is priced at $0.00, while TKBIF trades at $23.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas TKBIF's P/E ratio is 18.71. In terms of profitability, BRAXF's ROE is -2.49%, compared to TKBIF's ROE of N/A. Regarding short-term risk, BRAXF is more volatile compared to TKBIF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check TKBIF's competition here
BRAXF vs MPSYF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, MPSYF has a market cap of 2.8B. Regarding current trading prices, BRAXF is priced at $0.00, while MPSYF trades at $73.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas MPSYF's P/E ratio is -12.13. In terms of profitability, BRAXF's ROE is -2.49%, compared to MPSYF's ROE of -1.84%. Regarding short-term risk, BRAXF is more volatile compared to MPSYF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check MPSYF's competition here
BRAXF vs ONTTF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, ONTTF has a market cap of 2.7B. Regarding current trading prices, BRAXF is priced at $0.00, while ONTTF trades at $2.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas ONTTF's P/E ratio is -12.94. In terms of profitability, BRAXF's ROE is -2.49%, compared to ONTTF's ROE of -0.25%. Regarding short-term risk, BRAXF is more volatile compared to ONTTF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check ONTTF's competition here
BRAXF vs GLPGF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, GLPGF has a market cap of 2.2B. Regarding current trading prices, BRAXF is priced at $0.00, while GLPGF trades at $33.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas GLPGF's P/E ratio is -6.56. In terms of profitability, BRAXF's ROE is -2.49%, compared to GLPGF's ROE of -0.10%. Regarding short-term risk, BRAXF is more volatile compared to GLPGF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check GLPGF's competition here
BRAXF vs BRCTF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, BRCTF has a market cap of 2.2B. Regarding current trading prices, BRAXF is priced at $0.00, while BRCTF trades at $24.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas BRCTF's P/E ratio is 23.39. In terms of profitability, BRAXF's ROE is -2.49%, compared to BRCTF's ROE of +0.77%. Regarding short-term risk, BRAXF is more volatile compared to BRCTF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check BRCTF's competition here
BRAXF vs GENSF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, GENSF has a market cap of 2.2B. Regarding current trading prices, BRAXF is priced at $0.00, while GENSF trades at $33.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas GENSF's P/E ratio is -416.12. In terms of profitability, BRAXF's ROE is -2.49%, compared to GENSF's ROE of +0.01%. Regarding short-term risk, BRAXF is more volatile compared to GENSF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check GENSF's competition here
BRAXF vs MEOBF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, MEOBF has a market cap of 2B. Regarding current trading prices, BRAXF is priced at $0.00, while MEOBF trades at $1.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas MEOBF's P/E ratio is -15.40. In terms of profitability, BRAXF's ROE is -2.49%, compared to MEOBF's ROE of -0.12%. Regarding short-term risk, BRAXF is more volatile compared to MEOBF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check MEOBF's competition here
BRAXF vs ASCLF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, ASCLF has a market cap of 1.8B. Regarding current trading prices, BRAXF is priced at $0.00, while ASCLF trades at $1.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas ASCLF's P/E ratio is -47.50. In terms of profitability, BRAXF's ROE is -2.49%, compared to ASCLF's ROE of -0.06%. Regarding short-term risk, BRAXF is more volatile compared to ASCLF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check ASCLF's competition here
BRAXF vs PHMMF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, PHMMF has a market cap of 1.7B. Regarding current trading prices, BRAXF is priced at $0.00, while PHMMF trades at $96.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas PHMMF's P/E ratio is 34.66. In terms of profitability, BRAXF's ROE is -2.49%, compared to PHMMF's ROE of +0.21%. Regarding short-term risk, BRAXF is more volatile compared to PHMMF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check PHMMF's competition here
BRAXF vs BIESF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, BIESF has a market cap of 1.6B. Regarding current trading prices, BRAXF is priced at $0.00, while BIESF trades at $32.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas BIESF's P/E ratio is -44.44. In terms of profitability, BRAXF's ROE is -2.49%, compared to BIESF's ROE of -0.05%. Regarding short-term risk, BRAXF is more volatile compared to BIESF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check BIESF's competition here
BRAXF vs NURPF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, NURPF has a market cap of 1.4B. Regarding current trading prices, BRAXF is priced at $0.00, while NURPF trades at $10.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas NURPF's P/E ratio is 15.67. In terms of profitability, BRAXF's ROE is -2.49%, compared to NURPF's ROE of +0.49%. Regarding short-term risk, BRAXF is more volatile compared to NURPF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check NURPF's competition here
BRAXF vs HBMHF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, HBMHF has a market cap of 1.4B. Regarding current trading prices, BRAXF is priced at $0.00, while HBMHF trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas HBMHF's P/E ratio is 53.35. In terms of profitability, BRAXF's ROE is -2.49%, compared to HBMHF's ROE of +0.02%. Regarding short-term risk, BRAXF is more volatile compared to HBMHF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check HBMHF's competition here
BRAXF vs PPTDF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, PPTDF has a market cap of 1.3B. Regarding current trading prices, BRAXF is priced at $0.00, while PPTDF trades at $10.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas PPTDF's P/E ratio is -39.73. In terms of profitability, BRAXF's ROE is -2.49%, compared to PPTDF's ROE of +0.26%. Regarding short-term risk, BRAXF is more volatile compared to PPTDF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check PPTDF's competition here
BRAXF vs CSBTF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, CSBTF has a market cap of 1.3B. Regarding current trading prices, BRAXF is priced at $0.00, while CSBTF trades at $34.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas CSBTF's P/E ratio is -287.33. In terms of profitability, BRAXF's ROE is -2.49%, compared to CSBTF's ROE of -0.06%. Regarding short-term risk, BRAXF is more volatile compared to CSBTF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check CSBTF's competition here
BRAXF vs CSPHF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, CSPHF has a market cap of 1.2B. Regarding current trading prices, BRAXF is priced at $0.00, while CSPHF trades at $0.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas CSPHF's P/E ratio is -21.37. In terms of profitability, BRAXF's ROE is -2.49%, compared to CSPHF's ROE of +0.04%. Regarding short-term risk, BRAXF is more volatile compared to CSPHF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check CSPHF's competition here
BRAXF vs SNBIF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, SNBIF has a market cap of 1.2B. Regarding current trading prices, BRAXF is priced at $0.00, while SNBIF trades at $16.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas SNBIF's P/E ratio is -40.12. In terms of profitability, BRAXF's ROE is -2.49%, compared to SNBIF's ROE of -0.66%. Regarding short-term risk, BRAXF is more volatile compared to SNBIF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check SNBIF's competition here
BRAXF vs INRLF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, INRLF has a market cap of 977.9M. Regarding current trading prices, BRAXF is priced at $0.00, while INRLF trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas INRLF's P/E ratio is -10.65. In terms of profitability, BRAXF's ROE is -2.49%, compared to INRLF's ROE of -0.35%. Regarding short-term risk, BRAXF is more volatile compared to INRLF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check INRLF's competition here
BRAXF vs BTTAY Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, BTTAY has a market cap of 943M. Regarding current trading prices, BRAXF is priced at $0.00, while BTTAY trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas BTTAY's P/E ratio is -67.31. In terms of profitability, BRAXF's ROE is -2.49%, compared to BTTAY's ROE of -0.05%. Regarding short-term risk, BRAXF is more volatile compared to BTTAY. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check BTTAY's competition here
BRAXF vs PHGUF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, PHGUF has a market cap of 890.7M. Regarding current trading prices, BRAXF is priced at $0.00, while PHGUF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas PHGUF's P/E ratio is -130.00. In terms of profitability, BRAXF's ROE is -2.49%, compared to PHGUF's ROE of -0.03%. Regarding short-term risk, BRAXF is more volatile compared to PHGUF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check PHGUF's competition here
BRAXF vs BPMUF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, BPMUF has a market cap of 831M. Regarding current trading prices, BRAXF is priced at $0.00, while BPMUF trades at $67.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas BPMUF's P/E ratio is 9.93. In terms of profitability, BRAXF's ROE is -2.49%, compared to BPMUF's ROE of +1.59%. Regarding short-term risk, BRAXF is more volatile compared to BPMUF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check BPMUF's competition here
BRAXF vs IDRSF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, IDRSF has a market cap of 723.5M. Regarding current trading prices, BRAXF is priced at $0.00, while IDRSF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas IDRSF's P/E ratio is -3.76. In terms of profitability, BRAXF's ROE is -2.49%, compared to IDRSF's ROE of +0.12%. Regarding short-term risk, BRAXF is more volatile compared to IDRSF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check IDRSF's competition here
BRAXF vs VBIZF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, VBIZF has a market cap of 674.8M. Regarding current trading prices, BRAXF is priced at $0.00, while VBIZF trades at $0.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas VBIZF's P/E ratio is 32.44. In terms of profitability, BRAXF's ROE is -2.49%, compared to VBIZF's ROE of +0.04%. Regarding short-term risk, BRAXF is more volatile compared to VBIZF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check VBIZF's competition here
BRAXF vs SOLTF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, SOLTF has a market cap of 582.3M. Regarding current trading prices, BRAXF is priced at $0.00, while SOLTF trades at $6.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas SOLTF's P/E ratio is -25.74. In terms of profitability, BRAXF's ROE is -2.49%, compared to SOLTF's ROE of -0.07%. Regarding short-term risk, BRAXF is more volatile compared to SOLTF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check SOLTF's competition here
BRAXF vs CKDXF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, CKDXF has a market cap of 541.8M. Regarding current trading prices, BRAXF is priced at $0.00, while CKDXF trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas CKDXF's P/E ratio is -1.26. In terms of profitability, BRAXF's ROE is -2.49%, compared to CKDXF's ROE of +2.04%. Regarding short-term risk, BRAXF is more volatile compared to CKDXF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check CKDXF's competition here
BRAXF vs RAONF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, RAONF has a market cap of 451.7M. Regarding current trading prices, BRAXF is priced at $0.00, while RAONF trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas RAONF's P/E ratio is -43.33. In terms of profitability, BRAXF's ROE is -2.49%, compared to RAONF's ROE of -0.64%. Regarding short-term risk, BRAXF is more volatile compared to RAONF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check RAONF's competition here
BRAXF vs TBGNF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, TBGNF has a market cap of 433.7M. Regarding current trading prices, BRAXF is priced at $0.00, while TBGNF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas TBGNF's P/E ratio is -0.25. In terms of profitability, BRAXF's ROE is -2.49%, compared to TBGNF's ROE of N/A. Regarding short-term risk, BRAXF is more volatile compared to TBGNF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check TBGNF's competition here
BRAXF vs PTCHF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, PTCHF has a market cap of 432M. Regarding current trading prices, BRAXF is priced at $0.00, while PTCHF trades at $1.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas PTCHF's P/E ratio is 8.52. In terms of profitability, BRAXF's ROE is -2.49%, compared to PTCHF's ROE of +0.15%. Regarding short-term risk, BRAXF is more volatile compared to PTCHF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check PTCHF's competition here
BRAXF vs HLOSF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, HLOSF has a market cap of 429.1M. Regarding current trading prices, BRAXF is priced at $0.00, while HLOSF trades at $4.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas HLOSF's P/E ratio is -10.02. In terms of profitability, BRAXF's ROE is -2.49%, compared to HLOSF's ROE of -0.85%. Regarding short-term risk, BRAXF is more volatile compared to HLOSF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check HLOSF's competition here
BRAXF vs CLVLY Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, CLVLY has a market cap of 414.2M. Regarding current trading prices, BRAXF is priced at $0.00, while CLVLY trades at $8.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas CLVLY's P/E ratio is 16.80. In terms of profitability, BRAXF's ROE is -2.49%, compared to CLVLY's ROE of +0.19%. Regarding short-term risk, BRAXF is more volatile compared to CLVLY. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check CLVLY's competition here
BRAXF vs CLVLF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, CLVLF has a market cap of 399M. Regarding current trading prices, BRAXF is priced at $0.00, while CLVLF trades at $7.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas CLVLF's P/E ratio is 16.24. In terms of profitability, BRAXF's ROE is -2.49%, compared to CLVLF's ROE of +0.18%. Regarding short-term risk, BRAXF is more volatile compared to CLVLF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check CLVLF's competition here
BRAXF vs CYDY Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, CYDY has a market cap of 390.5M. Regarding current trading prices, BRAXF is priced at $0.00, while CYDY trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas CYDY's P/E ratio is -15.60. In terms of profitability, BRAXF's ROE is -2.49%, compared to CYDY's ROE of -0.04%. Regarding short-term risk, BRAXF is more volatile compared to CYDY. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check CYDY's competition here
BRAXF vs NWBO Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, NWBO has a market cap of 345M. Regarding current trading prices, BRAXF is priced at $0.00, while NWBO trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas NWBO's P/E ratio is -3.43. In terms of profitability, BRAXF's ROE is -2.49%, compared to NWBO's ROE of +0.92%. Regarding short-term risk, BRAXF is more volatile compared to NWBO. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check NWBO's competition here
BRAXF vs IVEVF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, IVEVF has a market cap of 317.2M. Regarding current trading prices, BRAXF is priced at $0.00, while IVEVF trades at $2.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas IVEVF's P/E ratio is -0.66. In terms of profitability, BRAXF's ROE is -2.49%, compared to IVEVF's ROE of +0.68%. Regarding short-term risk, BRAXF is more volatile compared to IVEVF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check IVEVF's competition here
BRAXF vs FGHQF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, FGHQF has a market cap of 305M. Regarding current trading prices, BRAXF is priced at $0.00, while FGHQF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas FGHQF's P/E ratio is 14.98. In terms of profitability, BRAXF's ROE is -2.49%, compared to FGHQF's ROE of +0.00%. Regarding short-term risk, BRAXF is more volatile compared to FGHQF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check FGHQF's competition here
BRAXF vs PBBIF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, PBBIF has a market cap of 286.9M. Regarding current trading prices, BRAXF is priced at $0.00, while PBBIF trades at $24.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas PBBIF's P/E ratio is 266.67. In terms of profitability, BRAXF's ROE is -2.49%, compared to PBBIF's ROE of +0.01%. Regarding short-term risk, BRAXF is more volatile compared to PBBIF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check PBBIF's competition here
BRAXF vs AVCTF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, AVCTF has a market cap of 285.7M. Regarding current trading prices, BRAXF is priced at $0.00, while AVCTF trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas AVCTF's P/E ratio is -6.47. In terms of profitability, BRAXF's ROE is -2.49%, compared to AVCTF's ROE of -3.40%. Regarding short-term risk, BRAXF is more volatile compared to AVCTF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check AVCTF's competition here
BRAXF vs PRRUF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, PRRUF has a market cap of 278.9M. Regarding current trading prices, BRAXF is priced at $0.00, while PRRUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas PRRUF's P/E ratio is -9.50. In terms of profitability, BRAXF's ROE is -2.49%, compared to PRRUF's ROE of -0.26%. Regarding short-term risk, BRAXF is more volatile compared to PRRUF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check PRRUF's competition here
BRAXF vs JWCTF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, JWCTF has a market cap of 267.7M. Regarding current trading prices, BRAXF is priced at $0.00, while JWCTF trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas JWCTF's P/E ratio is -3.30. In terms of profitability, BRAXF's ROE is -2.49%, compared to JWCTF's ROE of -0.41%. Regarding short-term risk, BRAXF is more volatile compared to JWCTF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check JWCTF's competition here
BRAXF vs ORYZF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, ORYZF has a market cap of 254.2M. Regarding current trading prices, BRAXF is priced at $0.00, while ORYZF trades at $3.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas ORYZF's P/E ratio is -46.86. In terms of profitability, BRAXF's ROE is -2.49%, compared to ORYZF's ROE of -0.04%. Regarding short-term risk, BRAXF is more volatile compared to ORYZF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check ORYZF's competition here
BRAXF vs CLTEF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, CLTEF has a market cap of 250.7M. Regarding current trading prices, BRAXF is priced at $0.00, while CLTEF trades at $3.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas CLTEF's P/E ratio is -3.50. In terms of profitability, BRAXF's ROE is -2.49%, compared to CLTEF's ROE of -0.43%. Regarding short-term risk, BRAXF is more volatile compared to CLTEF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check CLTEF's competition here
BRAXF vs NWPHF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, NWPHF has a market cap of 239.7M. Regarding current trading prices, BRAXF is priced at $0.00, while NWPHF trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas NWPHF's P/E ratio is N/A. In terms of profitability, BRAXF's ROE is -2.49%, compared to NWPHF's ROE of N/A. Regarding short-term risk, BRAXF is more volatile compared to NWPHF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check NWPHF's competition here
BRAXF vs SPHDF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, SPHDF has a market cap of 238.3M. Regarding current trading prices, BRAXF is priced at $0.00, while SPHDF trades at $18.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas SPHDF's P/E ratio is -4.01. In terms of profitability, BRAXF's ROE is -2.49%, compared to SPHDF's ROE of -1.01%. Regarding short-term risk, BRAXF is more volatile compared to SPHDF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check SPHDF's competition here
BRAXF vs HNSBF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, HNSBF has a market cap of 232.3M. Regarding current trading prices, BRAXF is priced at $0.00, while HNSBF trades at $2.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas HNSBF's P/E ratio is -3.04. In terms of profitability, BRAXF's ROE is -2.49%, compared to HNSBF's ROE of +1.21%. Regarding short-term risk, BRAXF is more volatile compared to HNSBF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check HNSBF's competition here
BRAXF vs MDCLF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, MDCLF has a market cap of 230.7M. Regarding current trading prices, BRAXF is priced at $0.00, while MDCLF trades at $6.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas MDCLF's P/E ratio is -5.21. In terms of profitability, BRAXF's ROE is -2.49%, compared to MDCLF's ROE of +0.89%. Regarding short-term risk, BRAXF is more volatile compared to MDCLF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check MDCLF's competition here
BRAXF vs CAIHF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, CAIHF has a market cap of 230.4M. Regarding current trading prices, BRAXF is priced at $0.00, while CAIHF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas CAIHF's P/E ratio is 2.80. In terms of profitability, BRAXF's ROE is -2.49%, compared to CAIHF's ROE of +0.05%. Regarding short-term risk, BRAXF is less volatile compared to CAIHF. This indicates potentially lower risk in terms of short-term price fluctuations for BRAXF.Check CAIHF's competition here
BRAXF vs SLNCF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, SLNCF has a market cap of 226.7M. Regarding current trading prices, BRAXF is priced at $0.00, while SLNCF trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas SLNCF's P/E ratio is -2.86. In terms of profitability, BRAXF's ROE is -2.49%, compared to SLNCF's ROE of -1.14%. Regarding short-term risk, BRAXF is more volatile compared to SLNCF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check SLNCF's competition here
BRAXF vs CMVLF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, CMVLF has a market cap of 224.9M. Regarding current trading prices, BRAXF is priced at $0.00, while CMVLF trades at $3.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas CMVLF's P/E ratio is -5.29. In terms of profitability, BRAXF's ROE is -2.49%, compared to CMVLF's ROE of -0.50%. Regarding short-term risk, BRAXF is more volatile compared to CMVLF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check CMVLF's competition here
BRAXF vs BOVNF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, BOVNF has a market cap of 216.4M. Regarding current trading prices, BRAXF is priced at $0.00, while BOVNF trades at $3.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas BOVNF's P/E ratio is -4.44. In terms of profitability, BRAXF's ROE is -2.49%, compared to BOVNF's ROE of -0.50%. Regarding short-term risk, BRAXF is more volatile compared to BOVNF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check BOVNF's competition here
BRAXF vs FPHAF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, FPHAF has a market cap of 209.5M. Regarding current trading prices, BRAXF is priced at $0.00, while FPHAF trades at $3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas FPHAF's P/E ratio is -7.50. In terms of profitability, BRAXF's ROE is -2.49%, compared to FPHAF's ROE of N/A. Regarding short-term risk, BRAXF is more volatile compared to FPHAF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check FPHAF's competition here
BRAXF vs VSBC Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, VSBC has a market cap of 207M. Regarding current trading prices, BRAXF is priced at $0.00, while VSBC trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas VSBC's P/E ratio is N/A. In terms of profitability, BRAXF's ROE is -2.49%, compared to VSBC's ROE of +0.00%. Regarding short-term risk, BRAXF is more volatile compared to VSBC. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check VSBC's competition here
BRAXF vs NGENF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, NGENF has a market cap of 192.9M. Regarding current trading prices, BRAXF is priced at $0.00, while NGENF trades at $2.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas NGENF's P/E ratio is -9.78. In terms of profitability, BRAXF's ROE is -2.49%, compared to NGENF's ROE of -4.00%. Regarding short-term risk, BRAXF is more volatile compared to NGENF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check NGENF's competition here
BRAXF vs IPHYF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, IPHYF has a market cap of 189.9M. Regarding current trading prices, BRAXF is priced at $0.00, while IPHYF trades at $2.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas IPHYF's P/E ratio is -2.90. In terms of profitability, BRAXF's ROE is -2.49%, compared to IPHYF's ROE of -2.63%. Regarding short-term risk, BRAXF is more volatile compared to IPHYF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check IPHYF's competition here
BRAXF vs GNFTF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, GNFTF has a market cap of 185.2M. Regarding current trading prices, BRAXF is priced at $0.00, while GNFTF trades at $3.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas GNFTF's P/E ratio is 124.00. In terms of profitability, BRAXF's ROE is -2.49%, compared to GNFTF's ROE of +0.02%. Regarding short-term risk, BRAXF is more volatile compared to GNFTF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check GNFTF's competition here
BRAXF vs BXPHF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, BXPHF has a market cap of 183.4M. Regarding current trading prices, BRAXF is priced at $0.00, while BXPHF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas BXPHF's P/E ratio is -9.35. In terms of profitability, BRAXF's ROE is -2.49%, compared to BXPHF's ROE of -0.21%. Regarding short-term risk, BRAXF is more volatile compared to BXPHF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check BXPHF's competition here
BRAXF vs BRIBF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, BRIBF has a market cap of 176.1M. Regarding current trading prices, BRAXF is priced at $0.00, while BRIBF trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas BRIBF's P/E ratio is -3.44. In terms of profitability, BRAXF's ROE is -2.49%, compared to BRIBF's ROE of -0.10%. Regarding short-term risk, BRAXF is more volatile compared to BRIBF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check BRIBF's competition here
BRAXF vs ADOCY Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, ADOCY has a market cap of 170.4M. Regarding current trading prices, BRAXF is priced at $0.00, while ADOCY trades at $11.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas ADOCY's P/E ratio is -3.36. In terms of profitability, BRAXF's ROE is -2.49%, compared to ADOCY's ROE of +1.73%. Regarding short-term risk, BRAXF is more volatile compared to ADOCY. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check ADOCY's competition here
BRAXF vs OPORF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, OPORF has a market cap of 164.9M. Regarding current trading prices, BRAXF is priced at $0.00, while OPORF trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas OPORF's P/E ratio is 12.00. In terms of profitability, BRAXF's ROE is -2.49%, compared to OPORF's ROE of +0.26%. Regarding short-term risk, BRAXF is more volatile compared to OPORF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check OPORF's competition here
BRAXF vs KNTPF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, KNTPF has a market cap of 158.4M. Regarding current trading prices, BRAXF is priced at $0.00, while KNTPF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas KNTPF's P/E ratio is -7.29. In terms of profitability, BRAXF's ROE is -2.49%, compared to KNTPF's ROE of +0.00%. Regarding short-term risk, BRAXF is more volatile compared to KNTPF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check KNTPF's competition here
BRAXF vs MLLCF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, MLLCF has a market cap of 155.6M. Regarding current trading prices, BRAXF is priced at $0.00, while MLLCF trades at $4.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas MLLCF's P/E ratio is -1.98. In terms of profitability, BRAXF's ROE is -2.49%, compared to MLLCF's ROE of -0.42%. Regarding short-term risk, BRAXF is more volatile compared to MLLCF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check MLLCF's competition here
BRAXF vs SCNLF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, SCNLF has a market cap of 147.7M. Regarding current trading prices, BRAXF is priced at $0.00, while SCNLF trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas SCNLF's P/E ratio is -4.74. In terms of profitability, BRAXF's ROE is -2.49%, compared to SCNLF's ROE of +2.45%. Regarding short-term risk, BRAXF is more volatile compared to SCNLF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check SCNLF's competition here
BRAXF vs AMGXF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, AMGXF has a market cap of 139.1M. Regarding current trading prices, BRAXF is priced at $0.00, while AMGXF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas AMGXF's P/E ratio is -0.46. In terms of profitability, BRAXF's ROE is -2.49%, compared to AMGXF's ROE of -0.14%. Regarding short-term risk, BRAXF is more volatile compared to AMGXF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check AMGXF's competition here
BRAXF vs AAPGV Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, AAPGV has a market cap of 127.3M. Regarding current trading prices, BRAXF is priced at $0.00, while AAPGV trades at $17.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas AAPGV's P/E ratio is N/A. In terms of profitability, BRAXF's ROE is -2.49%, compared to AAPGV's ROE of -0.79%. Regarding short-term risk, BRAXF is more volatile compared to AAPGV. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check AAPGV's competition here
BRAXF vs PSTTF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, PSTTF has a market cap of 117.5M. Regarding current trading prices, BRAXF is priced at $0.00, while PSTTF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas PSTTF's P/E ratio is -29.00. In terms of profitability, BRAXF's ROE is -2.49%, compared to PSTTF's ROE of N/A. Regarding short-term risk, BRAXF is more volatile compared to PSTTF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check PSTTF's competition here
BRAXF vs EPRXF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, EPRXF has a market cap of 108.3M. Regarding current trading prices, BRAXF is priced at $0.00, while EPRXF trades at $3.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas EPRXF's P/E ratio is -2.69. In terms of profitability, BRAXF's ROE is -2.49%, compared to EPRXF's ROE of -4.83%. Regarding short-term risk, BRAXF is more volatile compared to EPRXF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check EPRXF's competition here
BRAXF vs ADOIF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, ADOIF has a market cap of 103.7M. Regarding current trading prices, BRAXF is priced at $0.00, while ADOIF trades at $8.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas ADOIF's P/E ratio is -2.59. In terms of profitability, BRAXF's ROE is -2.49%, compared to ADOIF's ROE of +6.08%. Regarding short-term risk, BRAXF is more volatile compared to ADOIF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check ADOIF's competition here
BRAXF vs BSEM Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, BSEM has a market cap of 94.6M. Regarding current trading prices, BRAXF is priced at $0.00, while BSEM trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas BSEM's P/E ratio is 3.94. In terms of profitability, BRAXF's ROE is -2.49%, compared to BSEM's ROE of +1.50%. Regarding short-term risk, BRAXF is more volatile compared to BSEM. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check BSEM's competition here
BRAXF vs TRGNF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, TRGNF has a market cap of 92.6M. Regarding current trading prices, BRAXF is priced at $0.00, while TRGNF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas TRGNF's P/E ratio is -2.06. In terms of profitability, BRAXF's ROE is -2.49%, compared to TRGNF's ROE of -4.66%. Regarding short-term risk, BRAXF is more volatile compared to TRGNF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check TRGNF's competition here
BRAXF vs MCURF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, MCURF has a market cap of 86.5M. Regarding current trading prices, BRAXF is priced at $0.00, while MCURF trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas MCURF's P/E ratio is -16.90. In terms of profitability, BRAXF's ROE is -2.49%, compared to MCURF's ROE of -1.02%. Regarding short-term risk, BRAXF is more volatile compared to MCURF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check MCURF's competition here
BRAXF vs PBIGF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, PBIGF has a market cap of 82.8M. Regarding current trading prices, BRAXF is priced at $0.00, while PBIGF trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas PBIGF's P/E ratio is -6.94. In terms of profitability, BRAXF's ROE is -2.49%, compared to PBIGF's ROE of -0.66%. Regarding short-term risk, BRAXF is more volatile compared to PBIGF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check PBIGF's competition here
BRAXF vs ATGGF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, ATGGF has a market cap of 79.4M. Regarding current trading prices, BRAXF is priced at $0.00, while ATGGF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas ATGGF's P/E ratio is N/A. In terms of profitability, BRAXF's ROE is -2.49%, compared to ATGGF's ROE of -0.08%. Regarding short-term risk, BRAXF is more volatile compared to ATGGF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check ATGGF's competition here
BRAXF vs ACHFF Comparison August 2025
BRAXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRAXF stands at 1.3B. In comparison, ACHFF has a market cap of 77.4M. Regarding current trading prices, BRAXF is priced at $0.00, while ACHFF trades at $1.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRAXF currently has a P/E ratio of -0.03, whereas ACHFF's P/E ratio is -39.17. In terms of profitability, BRAXF's ROE is -2.49%, compared to ACHFF's ROE of +0.53%. Regarding short-term risk, BRAXF is more volatile compared to ACHFF. This indicates potentially higher risk in terms of short-term price fluctuations for BRAXF.Check ACHFF's competition here